University pharmacy spinout wins national start-up award
A spin-out company from Aston University’s pharmaceutics research group, MESOX, has won a major national medical technology and life sciences industry award.
MESOX, which was founded by Aston University pharmaceutics lecturer Dr Ali Al-Khattawi, has been awarded the National Start-Up Award from Medilink UK. The awards recognise outstanding contributions to medtech life sciences.
With in-depth expertise in particle engineering for drug delivery and pharmaceutical spray drying, MESOX uses IP-protected carriers to improve the bioavailability and efficacy of pharmaceuticals, partnering with pharmaceutical and biotechnology companies to bring challenging therapeutics to market.
MESOX won the Medilink Midlands Start-Up Award in May 2024, which is presented to a newly established company that shows a promising future. As a result of the win, MESOX went on to compete in the national awards against the other regional winners. The independent judging panel, representing key stakeholders in life sciences, assessed entrants in each of the seven categories on the merit of their contribution to the improvement of patient care.
The award was presented by Kevin Kiely MBE, executive chairman, Medilink North of England and Bill Cruise, chairman of Medilink UK, at a ceremony at the London Institute for Healthcare Engineering (LIHE).
Dr Al-Khattawi said: “This is a proud moment for the MESOX team and a testament to the potential of our company. To be selected from among hundreds of great life science start-ups in the UK is a great privilege. This highlights the transformative potential of our company in advancing the formulation development of innovative therapeutics.”
Bill Cruise said: “The Medilink UK Awards have once again been a tremendous success, and I offer my congratulations to all the award winners and finalists. Now, more than ever, we need the groundbreaking contributions of these and the many other companies across the Life Sciences sector to improve patient outcomes and provide efficiency.
“As a national industry support organisation, Medilink UK is pleased to work with our companies, adding value by helping them, and the Life Sciences sector as a whole, to grow, both nationally and internationally. We are proud to be contributing to their success, and I am confident that each of the companies who are here today will go on to do amazing things”.
